Prescribing Advice for GPs

An NHS Prescribing Advisers' Blog

Rosiglitazone on Panorama

Rosiglitazone (Avandia®, Avandamet®) will be the subject of the current affairs programme Panorama tonight. In particular the programme appears to be drawing attention to the cardiovascular risks of the drug and also to the ongoing safety review.

The European Medicines Agency has announced an additional meeting to review the complex data in order to finalise the review of rosiglitazone in time for the next scheduled meeting of 20-23 September 2010.

Panorama also claims that the Commission for Human Medicines, an advisory committee to the Medicines and Healthcare product Regulatory Agency (MHRA), voted unanimously in July for rosiglitazone to be withdrawn from the market. The contents of these meetings normally remain confidential until a full review is completed since it may not be in the public interest to release such information until the regulatory process being completed.

Action: Clinicians should be aware of this programme. Patients who are taking rosiglitazone currently may seek advice or request an alternative.

Share 'Rosiglitazone on Panorama' on Email Share 'Rosiglitazone on Panorama' on Delicious Share 'Rosiglitazone on Panorama' on Digg Share 'Rosiglitazone on Panorama' on Facebook Share 'Rosiglitazone on Panorama' on Google+ Share 'Rosiglitazone on Panorama' on reddit Share 'Rosiglitazone on Panorama' on StumbleUpon Share 'Rosiglitazone on Panorama' on Twitter

atomic-wealth

One Comments to “Rosiglitazone on Panorama”

  1. All glitazones should be withdawn from the market, see "Do not use glitazones either alone or in combination for treatment of diabetes" in
    Prescrire International 2008 ; 17 (97) : 189

    Comment by Christophe Kopp — September 6, 2010 #
    Reply

Leave a Comment

(required)

(required)


Prescribing Advice for GPs is powered by WordPress.
Subscribe for Free to our RSS or Atom Feeds for New Entries.
Akismet has protected Prescribing Advice for GPs from 789,318 spam comments.

atomic-wealth
fond-illness
summer